GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cytek Biosciences Inc.
Cytek Biosciences produces cell analysis instruments (cytometers) used in scientific research. Its stock price reflects demand for its equipment from biotech and pharmaceutical companies, as well as academic laboratories.
Share prices of companies in the market segment - Medanalysis
Cytek Biosciences, Inc. develops and manufactures innovative cell analysis instruments (flow cytometers) used in scientific research and diagnostics. We classify it in the Medical Analysis segment because its technologies expand the capabilities of scientists. The graph below illustrates the dynamics of this high-tech market.
Broad Market Index - GURU.Markets
Cytek Biosciences develops and manufactures innovative cell analysis instruments (flow cytometers) used in scientific research. As a key supplier, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Cytek's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
CTKB - Daily change in the company's share price Cytek Biosciences Inc.
The change_co indicator for Cytek Biosciences, a manufacturer of cell analysis instruments, measures its volatility. It reflects the sensitivity to R&D spending in the biotech sector. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medanalysis
Cytek Biosciences, Inc. is a manufacturer of cell analysis instruments. This chart highlights the high volatility of the life sciences sector. Comparing it to CTKB, a growing player, helps assess how its business model is ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Cytek is a manufacturer of cell analysis instruments (flow cytometry). Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess how the market is responding to breakthrough technologies.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cytek Biosciences Inc.
For Cytek Biosciences, Inc., the year-over-year performance is a story of the adoption of its innovative flow cytometers in scientific laboratories. The 12-month market capitalization growth reflects increased sales of its instruments, which enable more complex cellular analysis, and the expansion of its customer base among pharmaceutical companies and academic centers.
Annual dynamics of market capitalization of the market segment - Medanalysis
Cytek Biosciences, Inc. is a manufacturer of innovative flow cytometers for cell analysis. Its technology is changing approaches to biotech research. The chart shows how its technological leadership and rapid growth in this important niche are driving its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cytek, with its cell analysis tools, is a growth story in the life sciences. Its stock price is driven not by economics, but by demand from pharmaceutical companies and research centers for its innovative equipment. The chart reflects how technology accelerates scientific discovery.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cytek Biosciences Inc.
Cytek, a manufacturer of cell analysis instruments, depends on its R&D budgets for its performance. Monthly fluctuations on the chart reflect demand for its flow cytometers from research labs and biotech companies, making it sensitive to funding cycles in this field.
Monthly dynamics of market capitalization of the market segment - Medanalysis
Cytek Biosciences develops and markets cell analysis instruments (flow cytometers) that enable scientists and clinicians to study cells in detail. Their technology expands research capabilities. The graph below shows the overall dynamics of the medical analysis sector, which is growing alongside advances in cell biology and immunology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of life science equipment manufacturers are driven by pharmaceutical R&D budgets. The chart below shows the overall market sentiment. Does Cytek Biosciences follow these cycles, or does its innovative technology create its own demand?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cytek Biosciences Inc.
Cytek Biosciences, a manufacturer of cell analysis instruments (flow cytometry), is responding to news from the scientific world. Its weekly share price performance reflects demand for its equipment from research labs and pharmaceutical companies.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Cytek Biosciences, like other providers of biomedical research tools, reflects general trends in scientific funding. Pharmaceutical companies' R&D budgets and government grants create a common demand for all players. The chart shows whether CTKB is ahead of the industry thanks to the innovativeness of its technology.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cytek Biosciences, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on demand for its scientific equipment and regulatory decisions. The chart below clearly demonstrates how CTKB shares can live their own life, separate from the broader market.
Market capitalization of the company, segment and market as a whole
CTKB - Market capitalization of the company Cytek Biosciences Inc.
Cytek Biosciences' chart tells the story of innovation in cell analysis. The company produces flow cytometry instruments that allow scientists to analyze cells with high accuracy. Its market capitalization reflects how investors view the demand for its cutting-edge technologies from pharmaceutical and research labs.
CTKB - Share of the company's market capitalization Cytek Biosciences Inc. within the market segment - Medanalysis
Cytek Biosciences is a pioneer in full-spectrum flow cytometry, a cell analysis technology. Its share of its segment's market capitalization reflects its technological leadership. The chart below shows how investors assess its potential to transform biomedical research and diagnostics.
Market capitalization of the market segment - Medanalysis
Cytek Biosciences produces flow cytometers that enable detailed cell analysis. The chart below shows the market capitalization of the medical analysis sector. This is an estimate of the market for high-tech equipment that advances immunology, oncology, and other scientific fields.
Market capitalization of all companies included in a broad market index - GURU.Markets
Cytek Biosciences produces cell analysis instruments (flow cytometers) that enable scientists to study cells with unprecedented detail. The company's market capitalization reflects its technological leadership in this field. Its market share reflects the weight of its instruments that accelerate biological research and drug development.
Book value capitalization of the company, segment and market as a whole
CTKB - Book value capitalization of the company Cytek Biosciences Inc.
Cytek Biosciences' book value lies in the production of cellular analysis instruments. This includes assembly plants for unique full-spectrum flow cytometers, which enable scientists to obtain more data on cells, and R&D centers. The chart below shows how the company has invested in its knowledge-intensive manufacturing base.
CTKB - Share of the company's book capitalization Cytek Biosciences Inc. within the market segment - Medanalysis
Cytek Biosciences manufactures cell analyzers at its own manufacturing facilities. This high-tech infrastructure is its key tangible asset. The S_BCap_Seg chart shows its share of the medical analysis sector's physical assets.
Market segment balance sheet capitalization - Medanalysis
The life sciences sector, as the chart shows, requires unique assets. Cytek Biosciences is a prime example. Its business is capital-intensive, requiring manufacturing capabilities to create complex cellular analysis tools.
Book value of all companies included in the broad market index - GURU.Markets
Cytek Biosciences produces cell analysis instruments (cytometers) that allow scientists to study cells with unprecedented detail. The company's assets are the factories that create these "super-microscopes" for scientific breakthroughs. The chart below shows the financial weight behind this technological leader.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cytek Biosciences Inc.
Cytek's balance sheet is its factories producing unique instruments for cellular analysis. The market values it at a huge premium, seeing it not just as hardware, but as a technological leader giving scientists new eyes for studying life. The chart will show what price investors are paying for this scientific breakthrough.
Market to book capitalization ratio in a market segment - Medanalysis
Cytek Biosciences, Inc. produces innovative cell analysis instruments (cytometers). Its value lies in its unique technology, which enables it to obtain more data from a single sample. This chart illustrates the market premium it pays for its technological advantage in biomedical research.
Market to book capitalization ratio for the market as a whole
Cytek Biosciences develops and markets cell analysis instruments (cytometers) used in scientific research. The company's value lies in its innovative technology and patents. This chart shows how highly investors value its scientific potential and ability to compete in the high-tech laboratory equipment market.
Debts of the company, segment and market as a whole
CTKB - Company debts Cytek Biosciences Inc.
Cytek Biosciences, a manufacturer of cell analysis instruments, is leveraging its financial structure to fund R&D and global commercial expansion. This chart shows how the company is investing in the development of new generations of its flow cytometers and expanding its sales force to cement its technological leadership.
Market segment debts - Medanalysis
Cytek Biosciences develops and manufactures innovative flow cytometers for cellular analysis, used in scientific research and diagnostics. Rapid growth in the biotechnology equipment sector requires investment in R&D and manufacturing. This chart shows how the company is funding its expansion and technological leadership in this specialized market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cytek Biosciences Inc.
Cytek Biosciences develops and markets cell analysis tools used in research. This is a rapidly growing market that requires constant innovation. This chart shows how the company funds its R&D and global sales expansion, balancing growth with financial sustainability.
Market segment debt to market segment book capitalization - Medanalysis
Cytek Biosciences, a company that produces flow cytometers that enable detailed cell analysis, compares its debt to the overall market capitalization of the entire sector. It shows how the company, which offers innovative tools for scientific research, funds its development and commercial expansion.
Debt to book value of all companies in the market
Cytek Biosciences, Inc. develops and markets innovative cell analysis instruments used in scientific research. The Life Science Instruments sector is highly competitive. This chart shows overall debt trends, which helps assess how Cytek finances its R&D and marketing to advance its cutting-edge technology and increase market share.
P/E of the company, segment and market as a whole
P/E - Cytek Biosciences Inc.
This chart for Cytek Biosciences, Inc. shows the high valuation of the company, which has revolutionized cellular analysis with its full-spectrum flow cytometers. The high valuation reflects investors' faith in the company's technological excellence and the enormous potential of its instruments for biotech and pharmaceutical research.
P/E of the market segment - Medanalysis
Cytek Biosciences develops and manufactures flow cytometers—cell analysis instruments used in biological research and diagnostics. The company's technology enables the collection of more data from each cell. This chart illustrates the average rating in the biomedical analysis sector, which values technological innovation that expands scientists' capabilities.
P/E of the market as a whole
Cytek Biosciences develops and manufactures innovative cell analysis devices (cytometers) used in scientific research and diagnostics. This chart reflects the overall sentiment in the biotech sector. Comparisons with it help understand whether Cytek is perceived as a technology leader whose sales depend on research budgets, or whether its valuation follows general trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cytek Biosciences Inc.
For Cytek Biosciences, Inc., a manufacturer of cell analysis instruments, this chart illustrates market expectations for future sales of its equipment. It reflects analysts' belief in growing demand for advanced immunology and oncology technologies from research centers and laboratories.
%20P%2FE%20Cytek%20Biosciences%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Cytek-Biosciences-Inc.&v=1772560491522 "Chart of the company's future (projected) P/E Cytek Biosciences Inc.")
Future (projected) P/E of the market segment - Medanalysis
Cytek Biosciences, Inc. produces cell analysis instruments (cytometers) used in scientific research. This chart shows average expectations for the medical analysis sector. CTKB's position may indicate the extent to which investors believe in the superiority of its technology and the demand for its equipment from biotech and pharmaceutical companies.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772560491645 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Cytek Biosciences develops cell analysis tools used in research. Demand for its products depends on research budgets. General market optimism, reflected in this chart, is driving increased R&D funding from both government and private companies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772560491709 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Cytek Biosciences Inc.
Cytek Biosciences, Inc. develops and manufactures cell analysis instruments (flow cytometers) that enable researchers to obtain more data from a single sample. This chart shows how innovations in laboratory equipment generate revenue. Cytek's revenue growth reflects the growing adoption of its technology in research and clinical laboratories.
Profit of companies in the market segment - Medanalysis
Cytek Biosciences, Inc. is a company that manufactures cell analysis instruments (cytometers) used in scientific research. Profitability in the medical analytics sector, as this chart shows, is determined by the level of investment in biotechnology and pharmaceuticals. For CTKB, the technological superiority of its instruments is key to gaining market share in scientific research.
Overall market profit
Cytek Biosciences, a manufacturer of cell analysis instruments, operates in a market driven by pharmaceutical research and development. Demand for its products depends on R&D budgets. These budgets, in turn, correlate with overall sector profitability, as shown in this graph. Market growth allows companies to invest more in cutting-edge research.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cytek Biosciences Inc.
Cytek Biosciences produces cell analysis instruments (cytometers) used in scientific research. This chart shows the revenue forecast based on research budgets at biotech companies and academic institutions. It is an estimate of demand for its advanced analytical tools.
%20profit%20of%20the%20company%20Cytek%20Biosciences%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Cytek-Biosciences-Inc.&v=1772560491951 "Graph of future (projected) profit of the company Cytek Biosciences Inc.")
Future (predicted) profit of companies in the market segment - Medanalysis
Cytek Biosciences, Inc. develops and manufactures innovative cell analysis instruments (cytometers) that enable scientists to conduct more in-depth research. The company is a technology leader in its niche. This chart shows the revenue forecast for the medical analysis sector, reflecting expectations for biotechnology research expenditures.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772560492019 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Cytek Biosciences develops and markets cell analysis instruments used in scientific research. Demand for its products depends on funding from biotech companies and academic laboratories. A negative market outlook could mean a reduction in venture capital investment and government grants, potentially slowing the purchase of new equipment by Cytek's customers.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772560492206 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Cytek Biosciences Inc.
Cytek Biosciences develops and sells flow cytometers—instruments that analyze cells. They are widely used in scientific research and diagnostics. Its revenue depends on sales of this sophisticated equipment. The chart shows how highly the market values its technology, which offers more in-depth analysis of cell populations.
P/S market segment - Medanalysis
Cytek Biosciences develops and sells cell analysis instruments (flow cytometers) that enable scientists to conduct more in-depth research. The chart shows the average revenue estimate for the biomedical equipment sector. It helps assess the premium investors place on its cutting-edge technology compared to competitors.
P/S of the market as a whole
Cytek Biosciences, Inc. develops and manufactures cell analysis instruments (cytometers) used in scientific research and diagnostics. Its revenue depends on laboratory demand. This chart helps assess how the market values this high-tech scientific equipment manufacturer relative to the overall economy.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cytek Biosciences Inc.
Cytek Biosciences develops and manufactures innovative cell analysis instruments used in scientific research. This chart shows how the market values its cutting-edge technology, based on projected future sales of its flow cytometry systems to scientists and laboratories worldwide.
%20P%2FS%20Cytek%20Biosciences%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Cytek-Biosciences-Inc.&v=1772560492334 "The graph of the company's future (projected) P/S Cytek Biosciences Inc.")
Future (projected) P/S of the market segment - Medanalysis
Cytek Biosciences develops and manufactures innovative flow cytometers that enable deeper cellular analysis. This chart shows the average future revenue estimates for companies in the medical analysis sector. It provides insight into how the market perceives the technological advantages of Cytek's instruments and the demand for them from scientific and clinical laboratories.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772560492344 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Cytek Biosciences, Inc. develops and manufactures cell analysis instruments. Its clients include scientific laboratories and biopharmaceutical companies. Demand for its products depends on R&D budgets. This overall revenue expectation is less important to the company than the pace of innovation in biotechnology and cell therapy.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772560492374 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Cytek Biosciences Inc.
Cytek Biosciences develops and markets innovative cell analysis instruments (flow cytometers) used in scientific research. Revenue, shown in this chart, is driven by sales of its high-tech equipment. Sales growth reflects strong demand for advanced tools for biological and medical research.
Sales of companies in the market segment - Medanalysis
Cytek Biosciences, Inc. develops and manufactures innovative flow cytometers, devices for cellular analysis. Their technology enables scientists and clinicians to obtain more detailed information about individual cells, which is essential for research and diagnostics. This chart shows the sector's total revenue, reflecting the growing investment in biotechnology and personalized medicine.
Overall market sales
Cytek Biosciences, Inc. develops and manufactures cell analysis instruments (cytometers). This chart shows the overall economy, but for CTKB, the key driver is research spending in biotechnology and medicine. Its instruments are used to develop new drugs and diagnostics, and demand for them depends on the pace of innovation in these fields.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cytek Biosciences Inc.
Cytek Biosciences develops and manufactures flow cytometers—cell analysis tools used in scientific research. Demand for its products depends on research budgets in immunology and oncology. This graph shows the expected adoption of its cutting-edge technology in laboratories worldwide.
%20sales%20of%20the%20company%20Cytek%20Biosciences%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Cytek-Biosciences-Inc.&v=1772560492466 "Schedule of future (projected) sales of the company Cytek Biosciences Inc.")
Future (projected) sales of companies in the market segment - Medanalysis
Cytek Biosciences develops and manufactures flow cytometers—devices that enable scientists and physicians to analyze cells. The company's innovative technology enables more in-depth analysis. The chart shows forecasts for the medical analysis sector. Cytek's growth depends on the adoption of its technology in research labs and clinics.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772560492497 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Cytek Biosciences produces cell analysis instruments (cytometers) used in scientific research. Demand for its high-tech equipment depends on funding for science and R&D at biotech companies. This trend, reflecting overall economic confidence, influences investment in scientific research, which directly impacts CTKB sales.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772560492509 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Cytek Biosciences Inc.
Cytek Biosciences develops and manufactures innovative cell analysis instruments (cytometers) that are essential for medical research. The company's profitability depends on sales of its high-tech equipment. This chart shows how successfully Cytek is converting its scientific innovations into commercial products.
Market segment marginality - Medanalysis
Cytek Biosciences develops and manufactures cell analysis instruments (flow cytometers) that provide a deeper understanding of biology. This chart shows the average profitability in the life sciences sector. Innovative technology and growing demand from researchers allow the company to maintain high margins.
Market marginality as a whole
Cytek Biosciences, Inc. manufactures cell analysis instruments (cytometers) used in scientific research and diagnostics. Its success depends on technological excellence and investment in R&D. Given its overall corporate profitability, Cytek demonstrates how suppliers of high-tech scientific equipment can occupy a high-margin niche.
Employees in the company, segment and market as a whole
Number of employees in the company Cytek Biosciences Inc.
Cytek Biosciences develops cell analysis instruments. Its team includes engineers, development scientists, and a dedicated sales team. Its growth reflects investments in new technologies and a commercial team to promote them in the research market.
Share of the company's employees Cytek Biosciences Inc. within the market segment - Medanalysis
Cytek Biosciences develops and manufactures innovative cell analysis instruments (flow cytometers) that enable scientists to conduct more in-depth research. It's a high-tech business. This chart shows the percentage of specialists in the narrow niche of scientific instrumentation that Cytek attracts, reflecting its technological leadership and scientific authority in the industry.
Number of employees in the market segment - Medanalysis
Cytek Biosciences, Inc. develops and manufactures innovative cell analysis instruments (flow cytometers) used in scientific research. The rapid growth of its engineering, scientific, and sales staff, visible in the graph, reflects the high demand for its technology. The company is expanding to meet the needs of academic and pharmaceutical laboratories.
Number of employees in the market as a whole
Cytek Biosciences, Inc. produces cell analysis instruments. Its clients include research institutes and biotechnology companies. Research funding, which is indirectly linked to the overall health of the economy, as reflected in this chart, drives its development. Medical advances require increasingly sophisticated instruments, which is precisely what Cytek offers.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cytek Biosciences Inc. (CTKB)
Cytek Biosciences produces cell analysis instruments. It's a knowledge-intensive business, where value lies in technology and patents. This chart shows a high intellectual capital valuation. Each employee accounts for a significant portion of the value of unique developments and sophisticated equipment.
%20of%20the%20company%20Cytek%20Biosciences%20Inc.%20(CTKB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Cytek-Biosciences-Inc.-CTKB&v=1772560492754 "Chart of market capitalization per employee (in thousands of dollars) of the company Cytek Biosciences Inc. (CTKB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Cytek Biosciences, Inc. develops and manufactures innovative cell analysis devices (cytometers). It's a high-tech business where value is created by a team of scientists and engineers. This chart shows how the market values the company's intellectual capital and advanced technologies per employee.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772560492769 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Cytek Biosciences develops and markets cell analysis tools used in scientific research. This chart shows its valuation in the Life Science sector. Their high market capitalization per employee reflects the value of their innovative technology, which enables scientists to obtain more data at a lower cost.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772560492793 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cytek Biosciences Inc. (CTKB)
Cytek Biosciences produces cell analysis instruments (cytometers) used in scientific research. This is high-tech equipment. This graph shows how efficient their R&D and manufacturing business model is. It measures the net profit generated by each employee. This is an indicator of the value of their technologies in the biotech research market.
%20Chart%20Cytek%20Biosciences%20Inc.%20(CTKB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Cytek-Biosciences-Inc.-CTKB&v=1772560492820 "Company Profit Per Employee (in thousands of dollars) Chart Cytek Biosciences Inc. (CTKB)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Cytek Bio (CTKB) is a "Life Science Tools" company (cytometry equipment). This chart shows the benchmark for "Med-analysis" (Life Science Tools). The average profit per employee here is high (or negative if it's R&D). It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from "blades" (consumables).
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772560492842 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Cytek Biosciences (CTKB) develops and manufactures cell analysis instruments (flow cytometers) used in scientific research and diagnostics. It is a high-tech R&D and manufacturing business. This chart shows the profit generated by each employee creating complex and expensive scientific equipment.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772560492855 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Cytek Biosciences Inc. (CTKB)
Cytek Biosciences develops and markets cell analysis instruments. This chart shows how the company is commercializing its high-tech instruments. The increase in revenue per employee reflects strong demand from research institutes and biopharmaceutical companies, as well as the effectiveness of its sales team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Cytek-Biosciences-Inc.-CTKB&v=1772560492966 "Sales chart per company employee Cytek Biosciences Inc. (CTKB)")
Sales per employee in the market segment - Medanalysis
Cytek Biosciences (CTKB) produces high-tech equipment for cell analysis (flow cytometry). These are sophisticated scientific instruments. This graph shows their commercial and scientific productivity. Sales of expensive equipment and consumables for them allow Cytek to generate significant revenue per employee engaged in R&D and sales.
Sales per employee for the market as a whole
Cytek Biosciences produces innovative instruments for cell analysis (cytometers). This high-tech instrumentation technology is used in science and medicine. This metric reflects how effectively their R&D team creates in-demand instruments, and how effectively their sales team monetizes them by selling them to high-end laboratories.
Short shares by company, segment and market as a whole
Shares shorted by company Cytek Biosciences Inc. (CTKB)
Cytek Biosciences (CTKB) produces flow cytometry instruments—a technology that allows for the rapid analysis and sorting of millions of cells. Their innovation is spectral cytometry. This chart shows the bearish bets. Do the bears believe their technology is too niche, or that competitors (Becton Dickinson) won't cede market share?
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Cytek-Biosciences-Inc.-CTKB&v=1772560493051 "Short Shares Chart for the Company Cytek Biosciences Inc. (CTKB)")
Shares shorted by market segment - Medanalysis
Cytek Biosciences (CTKB) is a company that produces high-tech flow cytometers (cell analyzers) used in scientific research. This chart shows bets against the "scientific equipment" sector. Its rise reflects concerns that R&D budgets at pharmaceutical companies and laboratories (CTKB's clients) will be cut due to the recession.
Shares shorted by the overall market
Cytek Biosciences produces high-tech equipment for cell analysis. Its clients include scientific laboratories and biotech companies. When this chart shows rising fear, investors flee the biotech sector. This triggers a funding "winter," forcing labs, like CTKB, to freeze purchases of expensive new equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cytek Biosciences Inc. (CTKB)
Cytek Biosciences produces cell analysis equipment (cytometers). Its business depends on R&D budgets in biotech and academia. This chart, above 70, may reflect strong demand for its equipment. The range below 30 is associated with a "venture winter" and concerns about R&D budget cuts.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Cytek-Biosciences-Inc.-CTKB&v=1772560493185 "RSI 14 indicator chart for the company's stock Cytek Biosciences Inc. (CTKB)")
RSI 14 Market Segment - Medanalysis
Cytek Biosciences is a company that produces innovative flow cytometers (cell analysis instruments) that provide deeper cellular analysis. It's "hardware" for science. This chart measures the collective momentum in the life science instruments sector. It reveals whether the entire biotech sector is overheated or whether investors are evaluating Cytek's niche technology.
RSI 14 for the overall market
Cytek Biosciences (CTKB) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CTKB (Cytek Biosciences Inc.)
Cytek Biosciences (CTKB) is a company that produces cell analysis instruments (flow cytometers). Cytek's innovation (Full Spectrum Profiling) allows researchers to obtain significantly more data from a single cell. This chart shows the average analyst forecast, reflecting their assessment of the speed of adoption of this new technology in research labs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CTKB-Cytek-Biosciences-Inc.&v=1772560493255 "A chart showing analyst consensus forecasts for the expected stock price. CTKB (Cytek Biosciences Inc.)")
The difference between the consensus estimate and the actual stock price CTKB (Cytek Biosciences Inc.)
Cytek Biosciences is a manufacturer of cell analysis instruments (flow cytometry). Their full-spectrum cytometry (FSP) technology is a game-changer in bioresearch. This chart shows the difference between the market valuation and the analyst consensus forecast. It reveals whether experts believe in Cytek's technological superiority.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CTKB-Cytek-Biosciences-Inc.&v=1772560493264 "A chart showing the difference between the consensus forecast and the actual stock price. CTKB (Cytek Biosciences Inc.)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Cytek Biosciences is a manufacturer of flow cytometry instruments. Their technology allows scientists to analyze living cells with unprecedented detail. This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts believe demand for sophisticated R&D tools in biotech will grow.
Analysts' consensus forecast for the overall market share price
Cytek Biosciences (CTKB) is a supplier of biotech shovels. They produce advanced instruments (cytometers) for R&D. This chart of overall market sentiment is important. Optimism = biotechs easily raise money and spend it on R&D (buying CTKB equipment). Pessimism = venture winter = R&D freeze.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cytek Biosciences Inc.
Cytek Biosciences is a spectral revolution. They produce flow cytometers (cell analysis instruments), but their signature feature is full spectrum, which allows scientists to see many more colors (markers) on a single cell. This graph is an indicator of their technological breakthrough. It measures the rate of adoption of their expensive instruments in labs (R&D) and their superiority over older technology.
AKIMA Market Segment Index - Medanalysis
Cytek (CTKB) is a high-tech leader in cellular analysis; the company produces innovative flow cytometers (FACS) that (using a full spectrum) allow scientists to see much more cellular parameters. This summary metric evaluates R&D. The graph shows the sector average. This benchmark: how does this breakthrough (technology) model (CTKB) differentiate it from the average medtech competitor?
The AKIM Index for the overall market
Cytek Biosciences is a manufacturer of advanced flow cytometry systems for cell analysis. Their Full Spectrum Profiling technology accelerates research. This chart, reflecting the market average, is a backdrop. It helps assess how the CTKB, which depends on scientific equipment and laboratory budgets, compares to general macroeconomic fluctuations.
